Zhimeng Biopharma
Pudong
About Zhimeng Biopharma
Zhimeng is also actively developing novel small molecule drugs to treat neurological diseases, such as epilepsy, pains and strokes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $196.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2021)
- Website: core-biopharma.com
- Phone: +86 21-50391670
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/zhimeng-biopharma-46772 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.